Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm | News Direct

Kuehn Law Encourages Investors of Intellia Therapeutics, Inc. to Contact Law Firm

News release by Kuehn Law

facebook icon linkedin icon twitter icon pinterest icon email icon New York | April 02, 2024 10:37 AM Eastern Daylight Time

 

Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Intellia Therapeutics, Inc. (NASDAQ: NTLA) breached their fiduciary duties to shareholders. The investigation concerns potential self-dealing. Shareholders may be entitled to damages and corporate governance reforms.

If you own NTLA please contact Justin Kuehn, Esq. by email at justin@kuehn.law or call (833) 672-0814. The consultation and case are free with no obligation to you. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

Why Your Participation Matters:

As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.

For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.

Attorney advertising. Prior results do not guarantee similar outcomes.

 

Contact Details

 

Justin Kuehn

 

+1 833-672-0814

 

justin@kuehn.law

 

Company Website

 

https://www.kuehn.law/